Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Calibrate your expectations to receive the 4Q11 and 2011 OnBioVC Trend Analysis in January. Thanks to many of our dedicated readers who have checked in with us during a quiescent period in the late fall. Some interesting plans are in the works – based upon your feedback on the recent survey – more details to […]

OnBioVC continues to illuminate a deeply concerning financing trend observed over the last several years of aggregated data; one may term the resultant effect of this discernable development as an erosion in U.S.-based biomedical innovation. The metric invoked to quantify such bold nomenclature is simply the decline in first-time, Series A, institutional financings. With fewer […]

We are getting back after it at OnBioVC following an exciting week of incredibly helpful and insightful feedback from our audience. We will leave our survey open for a final 24 hours. If you have not completed the brief 5-question survey please click HERE to provide us your thoughts on how to improve the OnBioVC […]

Please help OnBioVC to help you to make more informed and thus better decisions. Information is power … what information will make you and your organization more potent, let us know by filling out this brief 5-question survey HERE. Your replies are held in the strictest confidence, no survey results are shared with an party. […]

OnBioVC has oodles of exciting expansion plans queued up for 2012. But if these new planned offerings are not indicated to be valuable to you, dear reader, well then it is back to the drawing board for us here at OnBioVC headquarters. So that brings us to tomorrow, where you have an opportunity to make […]

Hot off the press! The 2Q11 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 2Q11 OnBioVC Trend Analysis tracked, in aggregate, 80 biopharma, diagnostic, device, medical- IT and biofuel venture financings totaling $1,896.3M. Compared to 2Q10 OnBioVC data, this investment activity represents a decrease in […]

Please note the OnBioVC 1Q11 Trend Analysis has been UPDATED and is available HERE. Your fantastic feedback and enduring support of OnBioVC.com and the companion Trend Analysis study is exceedingly appreciated, keep those comments coming! Hard to believe the 2Q11 Trend Analysis will be available in just a few weeks. When summer roles around many […]

Hot off the press! The 1Q11 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 1Q11 OnBioVC Trend Analysis tracked, in aggregate, 62 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,176.7M. Compared to 1Q10 OnBioVC data, this investment activity represents a decrease in the […]

Hot off the press! The 4Q10 & 2010 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 2010 OnBioVC Trend Analysis tracked, in aggregate, 281 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $5,190.0M. Compared to 2009 OnBioVC data, this investment activity represents a decrease […]

Last call for OnBioVC partners… We are publishing the 2010 OnBioVC Trend Analysis mega-issue next week. Full-page Trend Analysis advertising opportunities plus a daily 125X pixel hyperlinked advert on OnBioVC.com partner opportunities are still available through Friday COB. If you are interested in cost-effectively reaching >45,000 life science professionals around the country and around the […]

Stick a fork in it as OnBioVC calls it a wrap for the Year. Be certain to keep your eyes peeled for the 4Q10 & 2010 OnBioVC Trend Analysis “Year-in-Review” mega-issue to be delivered to your inbox on or around 10 January. Advertising opportunities in the 2010 OnBioVC Trend Analysis are still available so be […]

NEW FUNDS OnBioVC is always excited to report on new funds. Provident Healthcare Ventures (Boston, MA) launched a $25M fund that is focused on investing in technologies associated with home-based healthcarecare, specialty pharma, hospice, infusion therapy and disease management. The fund will incubate early-stage start-ups and participate in more mature entities with investments ranging from […]

Hot off the press! The 3Q10 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 3Q10 OnBioVC Trend Analysis tracked, in aggregate, 70 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,420.0M. Compared to 3Q09 OnBioVC data, this investment activity represents a decrease in the […]

« Previous Page« Previous Entries  Next Entries »Next Page »

to top of page...